Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.44 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | NFE2L2 | Q16236 | 3/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13299432 | 0.86 | KDM4E (0.47) | KDM4EALDH1A1MAPTMEN1TP53 | |
| SCHEMBL15512 | 0.84 | KDM4E (0.47) | KDM4EMAPTMEN1KMT2ACA12 | |
| SCHEMBL1173259 | 0.83 | KDM4E (0.66) | KDM4EMAPTCYP1A2HPGDKMT2A | |
| SCHEMBL28528223 | 0.77 | ALDH1A1 (0.40) | KDM4EALDH1A1MAPTMEN1TP53 | |
| SCHEMBL24159780 | 0.76 | ALDH1A1 (0.47) | KDM4EALDH1A1MAPTMEN1TP53 | |
| SCHEMBL69522 | 0.76 | ALDH1A1 (0.58) | KDM4EALDH1A1MAPTMEN1TP53 | |
| SCHEMBL10438847 | 0.76 | ALDH1A1 (0.58) | KDM4EALDH1A1MAPTMEN1TP53 | |
| SCHEMBL11061667 | 0.75 | ALDH1A1 (0.56) | KDM4EALDH1A1MAPTMEN1TP53 | |
| SCHEMBL17695795 | 0.73 | KEAP1 (0.43) | NFE2L2 | |
| SCHEMBL156609 | 0.73 | ALDH1A1 (0.48) | KDM4EALDH1A1MAPTMEN1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 526 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119015394-A | Sulfur-containing compound preparation, and preparation method and application thereof | 上海优斐斯生物科技有限公司 | 2024-11-26 | — | — | CN | claimed |
| US-20240374492-A1 | A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION | ISP INVESTMENTS LLC (US) | 2024-11-14 | — | — | US | claimed |
| US-20240173235-A1 | PERSONAL CARE COMPOSITIONS COMPRISING SILAHYDROCARBONS | MOMENTIVE PERFORMANCE MATERIALS INC. | 2024-05-30 | — | — | US | claimed |
| EP-4322915-A1 | PERSONAL CARE COMPOSITIONS COMPRISING SILAHYDROCARBONS | Momentive Performance Materials Inc. (US) | 2024-02-21 | — | — | EP | claimed |
| CN-117425467-A | Personal care compositions comprising silicone based | 迈图高新材料公司 | 2024-01-19 | — | — | CN | claimed |
| WO-2023009315-A1 | A SUNSCREEN COMPOSITION COMPRISING AVOBENZONE AND A METHOD FOR PHOTOSTABILIZATION | ISP INVESTMENTS LLC (US) | 2023-02-02 | — | — | WO | claimed |
| WO-2022221354-A1 | PERSONAL CARE COMPOSITIONS COMPRISING SILAHYDROCARBONS | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2022-10-20 | — | — | WO | claimed |
| CN-112914020-A | Aqueous clear oil-in-water emulsions containing emulsified carotenoids | 巴斯夫欧洲公司 | 2021-06-08 | — | — | CN | claimed |
| EP-2874507-B1 | AQUEOUS TRANSPARENT OIL-IN-WATER EMULSION COMPRISING AN EMULSIFIED CAROTENOID | BASF SE (DE) | 2020-12-30 | — | — | EP | claimed |
| EP-2485807-B1 | SUN-CARE COMPOSITIONS | ISP INVESTMENTS LLC (US) | 2019-07-03 | — | — | EP | claimed |
| EP-1595936-A1 | ANTIOXIDATIVE COMPOSITION AND COMPOSITION FOR EXTERNAL USE | MITSUBISHI CORPORATION (JP) | 2005-11-16 | — | — | EP | claimed |
| US-20050249689-A1 | Personal care compositions with enhanced properties, method of manufacture, and method of use thereof | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-11-10 | — | — | US | claimed |
| US-20050249690-A1 | Personal care compositions with enhanced properties, method of manufacture, and method of use thereof | MOMENTIVE PERFORMANCE MATERIALS INC. | 2005-11-10 | — | — | US | claimed |
| EP-1107728-B1 | COSMETIC COMPOSITIONS FOR SOLAR PROTECTION AND USES | OREAL (FR) | 2004-04-28 | — | — | EP | claimed |
| EP-1002523-B1 | Cosmetic sunscreening compositions | OREAL (FR) | 2004-03-03 | — | — | EP | claimed |
| US-20040028642-A1 | Cosmetic composition comprising an extract of emblica officinalis and methods of using same | L'OREAL S.A. (FR) | 2004-02-12 | — | — | US | claimed |
| US-20020131939-A1 | Hair protection compositions | ROCHE VITAMINS INC. | 2002-09-19 | — | — | US | claimed |
| US-6409999-B2 | Synergistically UV-photoprotecting benzotriazole-substituted silicon/cinnamic acid compositions | SOCIETE L'OREAL (FR) | 2002-06-25 | — | — | US | claimed |
| US-20010041167-A1 | Synergistically UV-photoprotecting benzotriazole-substituted silicon/cinnamic acid compositions | SOCIETE L'OREAL S.A. (FR) | 2001-11-15 | — | — | US | claimed |
| US-6143282-A | TOPICAL APPLYING | SOCIETE L'OREAL S.A. (FR) | 2000-11-07 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010041167-A1 | Synergistically UV-photoprotecting benzotriazole-substituted silicon/cinnamic acid compositions | SUCLG1, ARNT, BPTF | KDM4E 3272/4885ALDH1A1 637/4885MAPT 999/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.